🔎 Trials Near Me

Home › Parkinson's Disease › Tennessee › Nashville

Parkinson's Disease clinical trials in Nashville, TN

15 studies for Parkinson's Disease are looking for participants at sites in and around Nashville (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

RecruitingPhase 2
  • Vanderbilt University, Nashville
Ages 40 to 80 · All sexes · Updated Oct 2, 2026 · NCT06680830

Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

RecruitingObservational study
  • Vanderbilt University Medical Center, Nashville
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT01734122

A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations

RecruitingPhase 2
  • Vanderbilt University Medical Center (Site #204), Nashville
Ages 30 to 80 · All sexes · Updated Sep 10, 2026 · NCT07432958

Parkinson's Foundation PD GENEration Genetic Registry

RecruitingObservational study
  • Vanderbilt University, Nashville
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT04994015

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

RecruitingPhase 3
  • Vanderbilt University Medical Center, Nashville
Ages 50 to 85 · All sexes · Updated Sep 3, 2026 · NCT07174310

Physiological Brain Atlas Development

RecruitingObservational study
  • Vanderbilt Univeristy, Nashville
Ages 6 to 90 · All sexes · Updated Aug 26, 2026 · NCT00575081

Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases

RecruitingPhase 4Healthy volunteers welcome
  • Vanderbilt University Medical Center, Nashville
Ages 50 to 85 · All sexes · Updated Aug 7, 2026 · NCT05357612

A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease

RecruitingPhase 3
  • Vanderbilt University Medical Center, Nashville
Ages 45 to 75 · All sexes · Updated Aug 4, 2026 · NCT06944522

Corticostriatal Contributions to Parkinson's Disease Cognitive Impairment

Recruiting
  • Vanderbilt University Medical Center, Nashville
Ages 40 and older · All sexes · Updated Jun 12, 2026 · NCT04715984

Neurophysiology of Reward Signaling in Parkinson's Disease

Recruiting
  • Vanderbilt University Medical Center, Nashville
Ages 40 and older · All sexes · Updated Jun 12, 2026 · NCT07409207

Natural History Study of Synucleinopathies

RecruitingObservational study
  • Vanderbilt Univeristy, Nashville
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT01799915

Use of CereGate Therapy for Freezing of Gait in PD

Recruiting
  • Vanderbilt University Medical Center, Nashville
Ages 21 to 80 · All sexes · Updated May 28, 2026 · NCT05292794

CPAP for the Treatment of Supine Hypertension

Recruiting
  • Autonomic Dysfunction Center/ Vanderbilt University Medical Center, Nashville
Ages 40 to 80 · All sexes · Updated Apr 7, 2026 · NCT05489575

[18F]F-DOPA Imaging in Patients With Autonomic Failure

RecruitingPhase 1Healthy volunteers welcome
  • Vanderbilt University Medical Center, Nashville
Ages 18 and older · All sexes · Updated Mar 16, 2026 · NCT04246437

Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure

RecruitingPhase 1
  • Autonomic Dysfunction Center/ Vanderbilt University Medical Center, Nashville
Ages 40 to 80 · All sexes · Updated Oct 14, 2025 · NCT02897063

About Parkinson's Disease

Parkinson's disease (PD) is a movement disorder. It causes tremors, stiffness, and slow movement. It gets worse over time. Learn what can help.

More about Parkinson's Disease on MedlinePlus

Parkinson's Disease trials in other cities

Other studies in Nashville

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.